Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has issued an announcement.
Imricor Medical Systems, Inc. announced the release of certain Class A Common Stock from voluntary escrow, in accordance with ASX Listing Rule 3.10A. This release involves the unlocking of 206,597 securities on 13 May 2025 and 78,987 securities on 16 May 2025. The release of these securities could potentially impact the company’s stock liquidity and investor interest, as it allows for increased trading activity. Additionally, Imricor’s CHESS Depositary Interests are restricted under the US Securities Act, limiting their sale to US persons, which maintains a controlled trading environment for these securities on the ASX.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. is a leader in developing MRI-compatible products for cardiac catheter ablation procedures. The company aims to enhance interventional medical procedures by enabling them to be performed under real-time MRI guidance, offering a safer and more effective alternative to traditional x-ray fluoroscopy. Imricor’s primary product, the Vision-MR Ablation Catheter, is approved in the EU, KSA, and New Zealand for treating type 1 atrial flutter, with plans for further regulatory approvals in the U.S. and other regions. The company collaborates with major MRI equipment vendors to establish iCMR labs in hospitals and clinics.
YTD Price Performance: 29.78%
Average Trading Volume: 396,982
See more insights into IMR stock on TipRanks’ Stock Analysis page.